Life in Pain

Affective Economy and the Demand for Pain Relief

John L. Fitzgerald

PDF
ca. 96,29
Amazon iTunes Thalia.de Hugendubel Bücher.de ebook.de kobo Osiander Google Books Barnes&Noble bol.com Legimi yourbook.shop Kulturkaufhaus ebooks-center.de
* Affiliatelinks/Werbelinks
Hinweis: Affiliatelinks/Werbelinks
Links auf reinlesen.de sind sogenannte Affiliate-Links. Wenn du auf so einen Affiliate-Link klickst und über diesen Link einkaufst, bekommt reinlesen.de von dem betreffenden Online-Shop oder Anbieter eine Provision. Für dich verändert sich der Preis nicht.

Springer Singapore img Link Publisher

Sozialwissenschaften, Recht, Wirtschaft / Sonstiges

Beschreibung

This book explores pain in a number of ways. At the heart of the book is an extension of Melzack’s neuromatrix theory of pain into the social, cultural, and economic fields. Specific assemblages involving varied institutions, flows of capital, encounters, and social and economic structures provide a framework for the formation of pain, its perception, experience, meaning, and cultural production. Complementing the extended neuromatrix is a second theory, focussed on the propensity of western market capitalism to seek out new areas of life to subsume to capital. Pain is one such life area that is now ripe for exploitation.
 
Although the book has theory at its heart, it draws extensively on case studies to identify the contradictions and complexities. Case studies are drawn from accounts of drug use in varied contexts such as prescription drugs,  methamphetamine use, oxycodone use in North America, and the global rise of the medicinal cannabis marketplace.
 

Weitere Titel von diesem Autor
Weitere Titel in dieser Kategorie
Cover Families and Religion
Christel Gärtner
Cover Antiracism
John Solomos

Kundenbewertungen

Schlagwörter

Medical Marijuana, Neuromatrix, Addiction, Affective Economy, Prescription Medication, Cannabis, Opioid, Pain Relief, Oxycodone, Chronic Pain, Methamphetamine, Illicit Drug Use, Ibuprofen, Psychoactive Drugs, Drug Market, Pain Medication, Pharmacoeconomics, Harm Reduction